Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Over 1%-15% of the population worldwide is affected by nephrolithiasis, which remains the most common and costly disease that urologists manage today. Identification of at-risk individuals remains a theoretical and technological challenge. The search for monogenic causes of stone disease has been largely unfruitful and a technological challenge; however, several candidate genes have been implicated in the development of nephrolithiasis. In this review, we will review current data on the genetic inheritance of stone disease, as well as investigate the evolving role of genetic analysis and counseling in the management of nephrolithiasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730897PMC
http://dx.doi.org/10.1016/j.ajur.2016.11.003DOI Listing

Publication Analysis

Top Keywords

development nephrolithiasis
8
technological challenge
8
stone disease
8
genetic framework
4
framework development
4
nephrolithiasis
4
nephrolithiasis 1%-15%
4
1%-15% population
4
population worldwide
4
worldwide nephrolithiasis
4

Similar Publications

Calcium oxalate (CaOx) stones are prevalent in urinary tract stone disease. While their formation can be induced in rats by administering ethylene glycol and vitamin D, the initial nucleation and formation processes are unclear. Here, we aimed to determine where CaOx crystals initially form, examine the associated histological and morphological changes, and clarify the genes whose expression varies at those sites and their function.

View Article and Find Full Text PDF

Ferroptosis is a new type of cell death driven by iron-dependent phospholipid peroxidation, which is regulated by a variety of factors including redox homeostasis, iron metabolism, lipid metabolism, cellular metabolism, and mitochondrial function, and plays an important driving role in the development of various tissues and organ damage and diseases. Kidney stones are a common urological disease characterized by high morbidity and high recurrence rate. Currently available preventive or therapeutic treatments for kidney stones are inadequate to cope with the growing clinical demand, suffering from poor efficacy and a higher risk of postoperative complications.

View Article and Find Full Text PDF

Our study aimed to analyzed the effectiveness and safety of tubeless mini percutaneous nephrolithotomy (tmPCNL) and negative pressure combined with retrograde intrarenal surgery (nRIRS) for 2 to 3 cm renal stones. A total of 557 patients underwent tmPCNL or nRIRS for renal stones in our department from October 2022 to February 2024. Combining inclusion and exclusion criteria, 153 cases were included and divided into tmPCNL group (n = 76) and nRIRS group (n = 77) according to the surgical method.

View Article and Find Full Text PDF

Background: Percutaneous nephrolithotomy (PCNL) is the standard treatment for large or complex renal stones; however, it carries risks such as bleeding and venous thromboembolism (VTE). Current guidelines do not recommend routine pharmacologic thromboprophylaxis in these patients due to concerns about bleeding and limited supporting evidence. This study evaluates the safety and efficacy of unfractionated heparin thromboprophylaxis in patients at moderate to high VTE risk undergoing PCNL.

View Article and Find Full Text PDF

Introduction: Percutaneous nephrolithotomy (PCNL) has undergone numerous technological innovations recently that make it even less invasive, but global adoption of these innovations remains unclear. This study sought to compare the effect of region and education on the penetrance of recent advances in PCNL worldwide.

Methods: An anonymous 32-item survey was developed and distributed via the Endourological Society's Twitter/X account in November 2023.

View Article and Find Full Text PDF